Luminex's Q3 Sales Rise 10 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Luminex reported after the close of the market a 10 percent rise in its third-quarter revenues, though the firm fell short of the consensus Wall Street estimate on the top line.

The Austin, Texas-based molecular diagnostics developer brought in total revenues of $50 million for the three months ended Sept. 30, up from $45.6 million for the third quarter of 2011. Analysts, on average, had expected revenues of $51.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.